B
BIO icon

Barings’s Bio-Rad Laboratories Class A BIO Stock Holding History

Barings’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,840
Closed -$810K – 940
2015
Q4 		$810K Hold
5,840
– – 0.02% 535
2015
Q3 		$784K Sell
5,840
-1,310
-18% -$189K 0.02% 523
2015
Q2 		$1.08M Buy
7,150
+1,950
+38% +$279K 0.03% 483
2015
Q1 		$703K Buy
+5,200
New +$645K 0.02% 604

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Barings's BIO Position: Q1 2016 in Review

Barings sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2016, closing a stake of 5,840 shares — an estimated $810K sold.

Barings first reported a position in BIO in Q1 2015 and held it in 4 quarters. The position peaked at $1.08M in Q2 2015. 232 funds tracked by Wall St. Rank hold BIO as of Q1 2016.

  • Barings reported no remaining Bio-Rad Laboratories Class A position as of Q1 2016 after selling out during the quarter.
  • Barings sold 5,840 Bio-Rad Laboratories Class A shares in Q1 2016, an estimated $810K.
  • Barings first reported a position in Bio-Rad Laboratories Class A in Q1 2015 and held it in 4 quarters.
  • Barings's Bio-Rad Laboratories Class A position peaked at $1.08M in Q2 2015.
  • 232 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2016.

Based on Barings's 13F filing for Q1 2016, filed 16 May 2016.